← Leaderboards
Christopher Mecoli
Johns Hopkins University
$1,860,567
Attributed
$1,860,567
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $575K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,860,567 · 2
By mechanism
R01$1,087,607 · 1
K23$772,960 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Susan D. Michaelis$14,317,975
- Livia A Casciola-Rosen$11,279,825
- Drew M. Pardoll$27,059,898
- Elizabeth Marion Jaffee$29,780,612
- David S Mandell$27,325,305
Others in their field
Other Emerging Leaders on “Radiation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$79,138,095
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$31,029,052
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
- Wendy Bergantz · University Of Chicago$13,233,874
Research focus
RadiationStandardizationMyositisPredictive ToolsSeer ProgramSiteHigh RiskMalignant NeoplasmsOnset Of IllnessPatient SubsetsDiagnosisScreening For CancerCancer RiskBiologicalAutoantibodiesGeneral PopulationIdiopathic Inflammatory MyopathiesInsightCancer DetectionCohortClinical Decision-MakingPathogenesisAntibodiesSubgroup
Grant awards (7)
Prediction and Significance of Cancer in Idiopathic Inflammatory Myositis$512,586
R01 · FY2025 · AR · contact PI
Prediction and Significance of Cancer in Idiopathic Inflammatory Myositis$575,021
R01 · FY2024 · AR · contact PI
Optimizing the Approach to Identify Cancer-Associated Myositis$154,592
K23 · FY2023 · AR · contact PI
Optimizing the Approach to Identify Cancer-Associated Myositis$154,592
K23 · FY2022 · AR · contact PI
Optimizing the Approach to Identify Cancer-Associated Myositis$154,592
K23 · FY2021 · AR · contact PI
Optimizing the Approach to Identify Cancer-Associated Myositis$154,592
K23 · FY2020 · AR · contact PI
Optimizing the Approach to Identify Cancer-Associated Myositis$154,592
K23 · FY2019 · AR · contact PI